News | FDA | August 18, 2023

Kitware leveraged the cutting-edge 3D Slicer medical visualization platform to develop custom medical imaging software and provided support throughout the FDA application process 

Kitware leveraged the cutting-edge 3D Slicer medical visualization platform to develop custom medical imaging software and provided support throughout the FDA application process

August 18, 2023 — Kitware, a leader in developing innovative medical visualization software, is pleased to announce its successful collaboration with Polarean, Inc. – a medical imaging technology company and long-standing customer – and their recent FDA-approval of their lung imaging technology. 

Polarean’s XENOVIEW VDP is image processing software that analyzes a pulmonary hyperpolarized 129Xe MR image and a proton chest MR image to provide visualization and evaluation of lung ventilation in adults and pediatric patients aged 12 years and older. This image analysis platform quantifies normalized xenon intensity of a ventilated space using a pulmonary hyperpolarized 129Xe ventilation MR image and accompanying proton chest MR image. The software, developed by Kitware based on Polarean’s technology will be used by clinicians to assist in the interpretation and numerical classification of hyperpolarized 129-Xe ventilation MR images. XENOVIEW VDP was built using 3D Slicer, an open-source medical imaging software that Kitware helps develop, and provides advanced 3D image analysis and structured clinical reporting tailored to the lung images acquired by XENOVIEW MRI technology.  

The Kitware team also supported Polarean’s FDA 510(k) application through technical guidance and documentation. Dr. Kiarash Emami, VP of Technology & Applications at Polarean remarked, "We have really enjoyed working with the Kitware team along the way and found them to be an excellent partner throughout this project." 

"Polarean's milestone is truly commendable, and we at Kitware extend our warmest congratulations," expressed Dr. Andinet Enquobahrie, Senior Director of Medical Computing at Kitware. “We believe in the power of innovation and collaboration and look forward to nurturing our collaboration to reach even greater heights in the future." 

Kitware has nearly 25 years of experience developing and deploying cutting-edge solutions for medical technology companies ranging from small companies like Polarean to Fortune 500 companies. Learn how Kitware can help bring impactful and innovative medical device technology to market.  

For more information: www.kitware.com 


Related Content

News | PET Imaging

May 29, 2026 — GE HealthCare recently announced that its MIM KineticID modeling software1 is now 510(k) pending with the ...

Time May 29, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
Subscribe Now